5VM

5AM Venture Management Portfolio holdings

AUM $260M
This Quarter Return
+32.72%
1 Year Return
+3.76%
3 Year Return
+144.87%
5 Year Return
+32.61%
10 Year Return
–
AUM
$297M
AUM Growth
+$297M
Cap. Flow
-$90.5M
Cap. Flow %
-30.48%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
6
Closed
–

Top Buys

1
FVAM
5:01 Acquisition Corp. Class A Common Stock
FVAM
$3.71M

Top Sells

1
ARVN icon
Arvinas
ARVN
$42.5M
2
IDYA icon
IDEAYA Biosciences
IDYA
$23.3M
3
QTTB icon
Q32 Bio
QTTB
$11.3M
4
AKUS
Akouos, Inc. Common Stock
AKUS
$9.32M
5
APRE icon
Aprea Therapeutics
APRE
$4.11M

Sector Composition

1 Healthcare 98.75%
2 Financials 1.25%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AKUS
1
DELISTED
Akouos, Inc. Common Stock
AKUS
$82M 27.62%
4,135,784
-470,000
-10% -$9.32M
QTTB icon
2
Q32 Bio
QTTB
$20.9M
$51.2M 17.25%
4,535,919
-1,000,000
-18% -$11.3M
ARVN icon
3
Arvinas
ARVN
$580M
$42.5M 14.3%
500,000
-500,000
-50% -$42.5M
CABA icon
4
Cabaletta Bio
CABA
$133M
$42.1M 14.17%
3,371,263
-298,000
-8% -$3.72M
IDYA icon
5
IDEAYA Biosciences
IDYA
$2.23B
$25.2M 8.48%
1,798,066
-1,665,000
-48% -$23.3M
SCPH icon
6
scPharmaceuticals
SCPH
$296M
$20.3M 6.83%
3,831,474
– –
CRNX icon
7
Crinetics Pharmaceuticals
CRNX
$3.14B
$19.2M 6.47%
1,362,286
– –
APRE icon
8
Aprea Therapeutics
APRE
$9.15M
$6.78M 2.28%
1,377,654
-835,000
-38% -$4.11M
CDTX icon
9
Cidara Therapeutics
CDTX
$1.62B
$4.01M 1.35%
2,006,511
– –
FVAM
10
DELISTED
5:01 Acquisition Corp. Class A Common Stock
FVAM
$3.71M 1.25%
+365,126
New +$3.71M